David E. Wheadon Net Worth

The estimated Net Worth of David E. Wheadon is at least $4.63 Million dollars as of 28 September 2020. David Wheadon owns over 48,346 units of Sotera Health Co stock worth over $4,627,847 and over the last 4 years David sold SHC stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

David Wheadon SHC stock SEC Form 4 insiders trading

David has made over 1 trades of the Sotera Health Co stock since 2020, according to the Form 4 filled with the SEC. Most recently David exercised 48,346 units of SHC stock worth $782,722 on 28 September 2020.

The largest trade David's ever made was exercising 48,346 units of Sotera Health Co stock on 28 September 2020 worth over $782,722. On average, David trades about 2,844 units every 0 days since 2020. As of 28 September 2020 David still owns at least 285,846 units of Sotera Health Co stock.

You can see the complete history of David Wheadon stock trades at the bottom of the page.

What's David Wheadon's mailing address?

David's mailing address filed with the SEC is C/O VAXART, INC., 170 HARBOR WAY, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Sotera Health Co

Over the last 4 years, insiders at Sotera Health Co have traded over $2,215,398,516 worth of Sotera Health Co stock. The most active insiders traders include Pincus & Co.Warburg Pincus ..., Pincus & Co.Warburg Pincus ..., and James Neary. On average, Sotera Health Co executives and independent directors trade stock every 84 days with the average trade being worth of $132,007,108. The most recent stock trade was executed by Pincus & Co.Warburg Pincus ... on 6 September 2024, trading 15,000,000 units of SHC stock currently worth $225,450,000.

What does Sotera Health Co do?

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

Complete history of David Wheadon stock trades at ChemoCentryx Inc, Vaxart Inc, Karuna Therapeutics Inc, Assertio, and Sotera Health Co

Sotera Health Co executives and stock owners

Sotera Health Co executives and other stock owners filed with the SEC include:

• Michael B. Petras Jr.,
  Chairman & CEO
• Scott J. Leffler,
  CFO & Treasurer
• Michael P. Rutz,
  Pres of Sterigenics
• Eric W. Beers,
  Sr. VP - Engineering
• Sally R. Turner,
  Chief HR Officer
• Kristin A. Gibbs,
  Chief Marketing Officer
• Kurt M. Roth,
  Sr. VP of Corp. Devel. & Strategy
• Terrence G. Hammons Jr., Esq.,
  Sr. VP, Gen. Counsel & Sec.
• Robert G. Hauzie,
  Chief Information Officer
• Kevin Theriault,
  Sr. VP of Operations
• Ann R. Klee,
  
• Pincus & Co.Warburg Pincus ...,
  
• Pincus & Co.Warburg Pincus ...,
  
• Stephanie Geveda,
  Director
• Investment Xi Llcgtcr Fund ...,
  
• James Neary,
  
• Pincus & Co.Warburg Pincus ...,
  
• Constantine S Mihas,
  
• Investment Xi Llcgtcr Fund ...,
  
• Pincus & Co.Warburg Pincus ...,
  
• Vincent K Petrella,
  
• Karen Flynn,
  
• Sean Laurence Cunningham,
  
• Michael P Rutz,
  President of Sterigenics
• Scott J. Leffler,
  CFO and Treasurer
• David Donnini,
  
• Matthew J Klaben,
  SVP, GC and Secretary
• Ruoxi Chen,
  
• David E. Wheadon,
  
• Terry Hammons,
  SVP, GC and Secretary
• Alexander Dimitrief,
  SVP, General Counsel and Sec.
• Robert Brown Knauss,
  
• Jonathan M. Lyons,
  Sr. Vice President, CFO
• Michael B. Jr. Petras,
  Chairman & CEO